Thursday, December 12, 2013

Oncogene - Table of Contents alert Volume 32 Issue 50

Oncogene

Advertisement

Finally! Antibodies you can TRUST.

Partnering with epigenetics experts including the BLUEPRINT Epigenome consortium, Diagenode has developed the absolute best epigenetics antibodies with the highest specificity and sensitivity available. Achieve unparalleled MeDIP, ChIP, and ChIP-seq results with validated antibodies you can trust. Learn more.


TABLE OF CONTENTS

Volume 32, Issue 50 (December 2013)

In this issue
Original Articles

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Win free sweets for your lab with Abcam® Imaging Products

http://www.abcam.com/sweetbox
 

Original Articles

Top

Signaling mediated by the NF-κB sub-units NF-κB1, NF-κB2 and c-Rel differentially regulate Helicobacter felis-induced gastric carcinogenesis in C57BL/6 mice OPEN

M D Burkitt, J M Williams, C A Duckworth, A O'Hara, A Hanedi, A Varro, J H Caamaño and D M Pritchard

Oncogene 2013 32: 5563-5573; advance online publication, August 26, 2013; 10.1038/onc.2013.334

Abstract | Full Text

Imiquimod directly inhibits Hedgehog signalling by stimulating adenosine receptor/protein kinase A-mediated GLI phosphorylation OPEN

F Wolff, A Loipetzberger, W Gruber, H Esterbauer, F Aberger and A M Frischauf

Oncogene 2013 32: 5574-5581; advance online publication, September 2, 2013; 10.1038/onc.2013.343

Abstract | Full Text

FER kinase promotes breast cancer metastasis by regulating α6- and β1-integrin-dependent cell adhesion and anoikis resistance OPEN

I A Ivanova, J F Vermeulen, C Ercan, J M Houthuijzen, F A Saig, E J Vlug, E van der Wall, P J van Diest, M Vooijs and P W B Derksen

Oncogene 2013 32: 5582-5592; advance online publication, July 22, 2013; 10.1038/onc.2013.277

Abstract | Full Text

A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity OPEN

R Castoldi, V Ecker, L Wiehle, M Majety, R Busl-Schuller, M Asmussen, A Nopora, U Jucknischke, F Osl, S Kobold, W Scheuer, M Venturi, C Klein, G Niederfellner and C Sustmann

Oncogene 2013 32: 5593-5601; advance online publication, July 1, 2013; 10.1038/onc.2013.245

Abstract | Full Text

Par-4/THAP1 complex and Notch3 competitively regulated pre-mRNA splicing of CCAR1 and affected inversely the survival of T-cell acute lymphoblastic leukemia cells OPEN

C Lu, J-Y Li, Z Ge, L Zhang and G-P Zhou

Oncogene 2013 32: 5602-5613; advance online publication, August 26, 2013; 10.1038/onc.2013.349

Abstract | Full Text

MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer OPEN

J Johansson, T Berg, E Kurzejamska, M-F Pang, V Tabor, M Jansson, P Roswall, K Pietras, M Sund, P Religa and J Fuxe

Oncogene 2013 32: 5614-5624; advance online publication, August 19, 2013; 10.1038/onc.2013.322

Abstract | Full Text

Advertisement
NATURE REVIEWS CANCER & NATURE REVIEWS CLINICAL ONCOLOGY
2014 CALENDAR 

Download the calendar for FREE

As well as plundering the Nature Reviews Cancer image bank for more clinically oriented figures for our 2014 calendar, we have chosen six images and figures from our sister journal, Nature Reviews Clinical Oncology.

Our calendar is freely available thanks to support from 
OriGene 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: